A NASH Trial Opportunity for Your Overweight Metabolic Syndrome Patients

A NASH Trial is underway at the centers listed below. Please view the videos to learn more about whether your patients might be eligible to participate.

Nonalcoholic fatty liver disease (NAFLD) and its more serious form, nonalcoholic steatohepatitis (NASH), are emerging as the most common chronic liver conditions in the Western world. With the unprecedented rise in the prevalence of these disorders, we have made significant advances in understanding how these conditions develop and how they can be managed. However, despite much active research in this area, we continue to wait for effective therapies to become available for use in our patients.

This pressing unmet need has been acknowledged by both the scientific and regulatory communities, who are working together to make effective therapies a reality.

For complete information
on this trial, visit


and search for the

RESOLVE-IT trial (NCT02704403)

For additional information on NASH & the RESOLVE-IT Trial, please click on the links below:


NASH Education Program

educational webcasts

on NASH provided by the Chronic Liver Disease Foundation

View Webcasts